IOVA Stock Jumps 35% On Positive Data
IOVA stock is on fire in Thursday’s session after Iovance Biotherapeutics Inc (NASDAQ:IOVA) announced positive results for its LN 145, an advanced cervical cancer drug. California-based biotechnology company, Iovance Biotherapeutics, has been one of the ... [Read]
Iovance Biotherapeutic Inc Sees Comeback From 12-Month Low
Iovance Biotherapeutics Inc. (NASDAQ:$IOVA) saw a 56.18% comeback from a 12-month low price of $4.45. It was seen 4.51% higher, changing the price to $6.95, when the closing bell rang on October 25th. During the ... [Read]